How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

How I Treat <i>TP53</i>-Mutated Acute Myeloid Leukemia and Myelodysplastic Syndromes

<i>TP53</i>-mutated acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) are among the myeloid malignancies with the poorest prognosis. In this review, we analyze the prognosis of these two diseases, focussing particularly on the extent of the mono or biallelic mutation statu...

Full description

Bibliographic Details
Main Authors: Michael Loschi, Pierre Fenaux, Thomas Cluzeau
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:Cancers
Subjects:
AML
<i>TP53</i>
magrolimab
eprenetapopt
allogeneic stem cell transplantation
Online Access:https://www.mdpi.com/2072-6694/14/18/4519

Internet

https://www.mdpi.com/2072-6694/14/18/4519

Similar Items